ROCKVILLE, Md., March 22, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSEAmerican:SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that Company’s Management will provide a corporate update and participate in a panel discussion entitled “Pancreatic Cancer: Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim 2022 Virtual Growth Conference, to be held virtually March 28-March 30, 2022.
Synthetic Biologics to Participate in the Maxim 2022 Virtual Growth Conference
Globe Newswire - Press Release 
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/A%20Palantir%20office%20building%20in%20Tokyo_%20Image%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock_.jpg)
/Semiconductor%20chip%20by%20Mykola%20Pokhodzhay%20via%20iStock.jpg)
/NVIDIA%20Corp%20logo%20on%20phone-by%20Evolf%20via%20Shutterstock.jpg)
/Ford%20Motor%20Co_%20logo%20by-%20Vera%20Tikhonova%20via%20iStock.jpg)